دورية أكاديمية

Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.

التفاصيل البيبلوغرافية
العنوان: Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.
المؤلفون: Balakumaran A; Skeletal Biology Section, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research., Mishra PJ; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, and., Pawelczyk E; Laboratory of Diagnostic Radiology Research, Warren G. Magnuson Clinical Center, National Institutes of Health, Department of Health and Human Services, Bethesda, MD;, Yoshizawa S; Skeletal Biology Section, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research., Sworder BJ; Skeletal Biology Section, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research., Cherman N; Skeletal Biology Section, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research., Kuznetsov SA; Skeletal Biology Section, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research., Bianco P; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy; and., Giri N; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute and., Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute and., Merlino G; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, and., Dumitriu B; Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD., Dunbar CE; Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD., Young NS; Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD., Alter BP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute and., Robey PG; Skeletal Biology Section, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research.
المصدر: Blood [Blood] 2015 Jan 29; Vol. 125 (5), pp. 793-802. Date of Electronic Publication: 2014 Dec 12.
نوع المنشور: Clinical Trial; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
أسماء مطبوعة: Publication: 2021- : [New York] : Elsevier
Original Publication: New York, Grune & Stratton [etc.]
مواضيع طبية MeSH: Bone Marrow Cells/*metabolism , Dyskeratosis Congenita/*genetics , Mesenchymal Stem Cells/*metabolism , RNA/*genetics , Telomerase/*genetics , Telomere/*metabolism, Adolescent ; Adult ; Animals ; Base Sequence ; Bone Marrow Cells/pathology ; Cell Differentiation ; Cell Proliferation ; Cellular Senescence ; Child ; Child, Preschool ; Colony-Forming Units Assay ; DNA Helicases/genetics ; DNA Helicases/metabolism ; Dyskeratosis Congenita/pathology ; Female ; Hematopoiesis/genetics ; Humans ; Male ; Mesenchymal Stem Cells/pathology ; Mice ; Middle Aged ; Molecular Sequence Data ; Mutation ; RNA/antagonists & inhibitors ; RNA/metabolism ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism ; Telomerase/antagonists & inhibitors ; Telomerase/metabolism ; Telomere/chemistry ; Telomere-Binding Proteins/genetics ; Telomere-Binding Proteins/metabolism
مستخلص: Dyskeratosis congenita (DC) is an inherited multisystem disorder, characterized by oral leukoplakia, nail dystrophy, and abnormal skin pigmentation, as well as high rates of bone marrow (BM) failure, solid tumors, and other medical problems such as osteopenia. DC and telomere biology disorders (collectively referred to as TBD here) are caused by germline mutations in telomere biology genes leading to very short telomeres and limited proliferative potential of hematopoietic stem cells. We found that skeletal stem cells (SSCs) within the BM stromal cell population (BMSCs, also known as BM-derived mesenchymal stem cells), may contribute to the hematologic phenotype. TBD-BMSCs exhibited reduced clonogenicity, spontaneous differentiation into adipocytes and fibrotic cells, and increased senescence in vitro. Upon in vivo transplantation into mice, TBD-BMSCs failed to form bone or support hematopoiesis, unlike normal BMSCs. TERC reduction (a TBD-associated gene) in normal BMSCs by small interfering TERC-RNA (siTERC-RNA) recapitulated the TBD-BMSC phenotype by reducing proliferation and secondary colony-forming efficiency, and by accelerating senescence in vitro. Microarray profiles of control and siTERC-BMSCs showed decreased hematopoietic factors at the messenger RNA level and decreased secretion of factors at the protein level. These findings are consistent with defects in SSCs/BMSCs contributing to BM failure in TBD.
References: Nat Rev Cancer. 2011 Mar;11(3):161-76. (PMID: 21346783)
Cell. 2007 Jun 15;129(6):1097-110. (PMID: 17574023)
J Bone Miner Res. 2011 Jul;26(7):1494-505. (PMID: 21308778)
Mutat Res. 2012 Feb 1;730(1-2):43-51. (PMID: 21745483)
Haematologica. 2012 Mar;97(3):353-9. (PMID: 22058220)
J Transl Med. 2012;10:207. (PMID: 23038994)
Haematologica. 2013 Mar;98(3):334-8. (PMID: 22899577)
J Tissue Eng Regen Med. 2013 Mar;7(3):226-35. (PMID: 22052864)
Blood. 2007 Sep 1;110(5):1439-47. (PMID: 17468339)
Aging Cell. 2008 Jan;7(1):23-31. (PMID: 18028256)
Curr Opin Hematol. 2008 May;15(3):162-8. (PMID: 18391779)
Stem Cell Res. 2009 Jan;2(1):83-94. (PMID: 19383412)
Biochim Biophys Acta. 2009 Apr;1792(4):371-9. (PMID: 19419704)
Nature. 2009 Jul 2;460(7251):66-72. (PMID: 19571879)
Nature. 2009 Jul 9;460(7252):259-63. (PMID: 19516257)
Nature. 2010 Apr 8;464(7290):852-7. (PMID: 20305640)
Br J Haematol. 2010 Jul;150(2):179-88. (PMID: 20507306)
Nature. 2010 Aug 12;466(7308):829-34. (PMID: 20703299)
Immunity. 2010 Sep 24;33(3):387-99. (PMID: 20850355)
Nature. 2011 Jun 16;474(7351):399-402. (PMID: 21602826)
Am J Pathol. 1997 Dec;151(6):1587-600. (PMID: 9403710)
J Clin Invest. 1998 Apr 15;101(8):1737-44. (PMID: 9541505)
Crit Rev Eukaryot Gene Expr. 1999;9(2):159-73. (PMID: 10445154)
Methods Cell Biol. 2004;75:719-50. (PMID: 15603450)
J Cell Biol. 2004 Dec 20;167(6):1113-22. (PMID: 15611335)
EMBO Rep. 2005 Mar;6(3):268-74. (PMID: 15731767)
N Engl J Med. 2005 Apr 7;352(14):1413-24. (PMID: 15814878)
Cell. 2005 Jul 1;121(7):1109-21. (PMID: 15989959)
J Cell Physiol. 2005 Nov;205(2):228-36. (PMID: 15887229)
Nature. 2013 Mar 14;495(7440):231-5. (PMID: 23434755)
Hum Genet. 2013 Apr;132(4):473-80. (PMID: 23329068)
J Clin Invest. 2013 May;123(5):1952-63. (PMID: 23585473)
Expert Rev Hematol. 2013 Jun;6(3):327-37. (PMID: 23782086)
J Exp Med. 2013 Jul 1;210(7):1351-67. (PMID: 23776077)
Biol Blood Marrow Transplant. 2013 Aug;19(8):1238-43. (PMID: 23751955)
EMBO J. 2013 Oct 2;32(19):2535-47. (PMID: 24022369)
Semin Hematol. 2013 Oct;50(4):333-47. (PMID: 24246701)
Cell. 2007 Oct 19;131(2):324-36. (PMID: 17956733)
Nature. 2003 Oct 23;425(6960):841-6. (PMID: 14574413)
Cell. 2004 Jul 23;118(2):149-61. (PMID: 15260986)
Transplantation. 1974 Apr;17(4):331-40. (PMID: 4150881)
Exp Hematol. 1976 Sep;4(5):267-74. (PMID: 976387)
Blood Cells. 1978;4(1-2):7-25. (PMID: 747780)
J Cell Physiol. 1981 Aug;108(2):155-61. (PMID: 7263769)
Exp Hematol. 1986 Oct;14(9):833-9. (PMID: 3019748)
Ciba Found Symp. 1988;136:42-60. (PMID: 3068016)
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1502-6. (PMID: 1371359)
Bioessays. 1993 Feb;15(2):77-83. (PMID: 7682413)
Calcif Tissue Int. 1996 Oct;59(4):265-70. (PMID: 8781050)
J Exp Med. 1997 Jan 6;185(1):111-20. (PMID: 8996247)
Transplantation. 1997 Apr 27;63(8):1059-69. (PMID: 9133465)
J Bone Miner Res. 1997 Sep;12(9):1335-47. (PMID: 9286749)
Stem Cells. 2005 Oct;23(9):1357-66. (PMID: 16081661)
Haematologica. 2006 Aug;91(8):1017-26. (PMID: 16870554)
Methods Enzymol. 2006;419:117-48. (PMID: 17141054)
Immunity. 2006 Dec;25(6):977-88. (PMID: 17174120)
Blood. 2010 Oct 14;116(15):e41-55. (PMID: 20647571)
معلومات مُعتمدة: GGP09227 Italy TI_ Telethon; United States Intramural NIH HHS
سلسلة جزيئية: GENBANK NM002046; NM138712
المشرفين على المادة: 0 (RNA, Small Interfering)
0 (TINF2 protein, human)
0 (Telomere-Binding Proteins)
0 (telomerase RNA)
63231-63-0 (RNA)
EC 2.7.7.49 (TERT protein, human)
EC 2.7.7.49 (Telomerase)
EC 3.6.1.- (RTEL1 protein, human)
EC 3.6.4.- (DNA Helicases)
تواريخ الأحداث: Date Created: 20141216 Date Completed: 20150413 Latest Revision: 20220129
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC4311227
DOI: 10.1182/blood-2014-06-566810
PMID: 25499762
قاعدة البيانات: MEDLINE
الوصف
تدمد:1528-0020
DOI:10.1182/blood-2014-06-566810